XML 28 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (audited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Series C Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Balance at Dec. 31, 2019 $ (123,338)       $ 4,419 $ (127,757)
Balance, Shares at Dec. 31, 2019   209,119,674   230,860    
Temporary equity balance, Value at Dec. 31, 2019   $ 130,666        
Issuance of Series C redeemable convertible preferred stock, net of issuance costs     $ 29,446      
Issuance of Series C redeemable convertible preferred stock, net of issuance costs, Shares     78,306,611      
Accretion of convertible preferred stock to redemption value (115)       (115)  
Temporary equity, Accretion of convertible preferred stock to redemption value   $ 115        
Issuance of common stock warrants in conjunction with sale of Series C redeemable convertible preferred stock 740       740  
Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering 160,227   $ (160,227) $ 8 160,219  
Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering, Shares     (287,426,285) 8,335,248    
Issuance of common stock from initial public offering, net of issuance costs 57,284     $ 4 57,280  
Issuance of common stock from initial public offering, net of issuance costs, Shares       4,025,000    
Vesting of restricted common stock       24,661    
Issuance of common stock upon exercise of warrants       $ 1 (1)  
Issuance of common stock upon exercise of warrants, Shares       313,794    
Exercise of common stock options 8       8  
Exercise of common stock options, Shares       2,814    
Stock-based compensation 1,813       1,813  
Net loss (22,127)         (22,127)
Balance at Dec. 31, 2020 74,492     $ 13 224,363 (149,884)
Balance, Shares at Dec. 31, 2020       12,932,377    
Vesting of restricted common stock       2,600    
Exercise of common stock options $ 604       604  
Exercise of common stock options, Shares 72,201     72,201    
Stock-based compensation $ 2,733       2,733  
Net loss (43,513)         (43,513)
Balance at Dec. 31, 2021 $ 34,316     $ 13 $ 227,700 $ (193,397)
Balance, Shares at Dec. 31, 2021       13,007,178